Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05028972 · ClinicalTrials.gov registry record · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
A NA study of Hearing Loss and Hospital Readmission, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 1,050
- Enrollment target
- 6
- Study locations
NCT05028972: Recruiting NA study of Hearing Loss and Hospital Readmission, sponsored by VA Office of Research and Development.
NCT05028972 is a NA study of Hearing Loss and Hospital Readmission that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 1,050 participants, below the 6,103-participant average among 58 other Hearing Loss trials with a reported enrollment target (83% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05028972, a NA study of Hearing Loss and Hospital Readmission, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,050 participants
- Enrollment target
- 6
- Study locations
Study Summary
HearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their hearing, enhance understanding of discharge instructions, and can reduce the risk of coming back to the ED in a short period of time (3 days and 30 days). The second part of the study will then identify whether ED staff can implement this program and achieve similar results. The second part will give ED staff increasing levels of responsibility for screening Veterans for hearing difficulty and providing personal amplifiers when such difficulty is detected.
Primary Outcome
The Investigators will determine whether patients have had an ED revisit within three days through CPRS review as well as a brief follow-up phone call 3-5 days after ED discharge
Conditions Studied
Interventions
- OTHER Personal Amplifier
- OTHER No Personal Amplifier
Study Locations (6)
New York
- VA NY Harbor Healthcare System, New York, NY - New York
- Syracuse VA Medical Center, Syracuse, NY - Syracuse
- James J. Peters VA Medical Center, Bronx, NY - The Bronx
Colorado
- Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora
North Carolina
- Durham VA Medical Center, Durham, NC - Durham
Texas
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,050 participants |
| Start Date | 2021-12-08 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT05028972 shows while recruiting
NCT05028972 is an interventional study that assigns participants to a tested intervention. Its 1,050 participants enrollment target places it among the larger protocols in the corpus, below the 6,103-participant average among 58 other Hearing Loss trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Personal Amplifier is the first listed.
NCT05028972 lists 6 locations in 4 states (New York, Colorado, North Carolina).
Frequently Asked Questions
What is clinical trial NCT05028972 about?
NCT05028972 is a clinical study titled "Hearing Impairment, Strategies and Outcomes in VA Emergency Departments". HearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their hearing, enhance und...
What is the current status of trial NCT05028972?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,050 participants. The study started on 2021-12-08. Estimated completion is 2026-09-30.
What conditions does trial NCT05028972 study?
This clinical trial studies the following conditions: Hearing Loss, Hospital Readmission, Emergency Service.
What interventions are being tested in trial NCT05028972?
The interventions under investigation include: Personal Amplifier (OTHER), No Personal Amplifier (OTHER).
Who is sponsoring clinical trial NCT05028972?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05028972 being conducted?
This trial has 6 study locations across Colorado, New York, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05028972's enrollment target sits among peer trials
1,050 8th of 58 higher than 51 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
- NCT05958342 · 1,050 participants · Phase 2
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI